Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/5/21 → 10/4/24 |
Funding
- Fortrea Incorporated: $30,325.00
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 Alone and In Combination With Nivolumab In Patients With Advanced Solid Tumors
- Arnold, Susanne (PI)